Navigation Links
220 Companies Place Switzerland First in Biotech Density Per Capita

14,000 Employees in Industry with Revenues of 7 Billion Swiss Francs

300+ Research Groups Focus on Biotech

NEW YORK, June 3 /PRNewswire/ -- With 148 biotech companies and 72 suppliers to the industry -- or 220 firms involved in the business -- Switzerland has the world's highest biotech density per capita, reports Mario Brossi of the foreign investment agency Location Promotion Switzerland ( "These firms employ 14,000 people and have an annual turnover of 7 billion Swiss francs," he says. "Supporting the industry are more than 300 research groups at universities and other public institutions focusing on biotechnology."

On Wednesday, June 18th during BIO 2008 at the San Diego Convention Center, Mr. Brossi will review Switzerland's biotech strong points as a participant on the International Competitiveness Panel discussion, 2:00 - 3:30 p.m., Room 24 B-C.

Swiss Investment Credentials -- One Nation, One Biotech Cluster

"New investors pumped a record 885 million francs into Swiss biotech in 2007, up from the previous record -- 780 million in '06," Mr. Brossi says. "This vote of confidence echoes a report by The Institute of Management Development in Lausanne, which has declared Switzerland the best nation for basic research and knowledge transfer between industry and academia. More than 40 technology parks throughout the country support the increasingly important tech transfer process."

Intellectual property protection is one of Switzerland's strong suits, Mr. Brossi says. "For example, the Swiss Federal Institute of Intellectual Property recently addressed the issue of biotechnological innovations concerning the extent of protection given to nucleic acid sequences. The legislation is expected to come into force on July 1 of this year." He adds that Switzerland is a leading research nation, ranking top in terms of publications per person, and that in terms of relative citation impact, Switzerland ranks first in immunology, molecular biology, pharmacology and physics.

The Swiss Biotech Business Environment -- Access to Markets and Talent

While Switzerland is not a member of the EU, a series of bilateral agreements with the EU make certain that goods, services and personnel move freely between the country and EU member nations, Mr. Brossi explains. Outside Europe, the U.S. and Canada are among the country's major trading partners.

"To help the industry secure needed talent Switzerland has opened its labor market to the 15 original EU and 5 EFTA Nations by eliminating a quota system," Mr. Brossi says. "This eases staffing tasks for companies requiring skilled personnel in excess of those graduating from Swiss universities and institutes of technology. Foreign-based firms as well as Switzerland's own companies now can draw staff from among the best Europe has to offer."

Overall Business Climate

A country's ranking in recognized economic studies provides some help in making foreign direct investment decisions across many businesses. Some examples of Switzerland's rankings:

-- 1st in Europe in the 2008 World Competitiveness Yearbook published by

The Institute of Management Development.

-- 2nd in the 2007-2008 Global Competitiveness Report and 3rd in the

2007-2008 Global IT Report published by the World Economic Forum.

-- 3rd in Europe as the best place in the world to conduct business over

the next five years, according to the Economist Intelligence Unit's

latest business environment rankings.

-- 2nd in Europe in the 2008 Index of Economic Freedom published by

The Heritage Foundation/The Wall Street Journal.

The Swiss Tax Environment

According to recent surveys of European tax regimes, Switzerland's tax system is one of the leaders in terms of overall attractiveness, ease of filing and rate of taxation.

"Tax incentives for new and expanding businesses are available at the Federal and cantonal (state) level," Mr. Brossi says. "Almost every one of the 26 cantonal tax laws provide for either relief or exemption from taxes, although the degree of relief or exception varies from canton to canton and on the business being conducted. All taxes are set at the cantonal level, which simplifies things, and generally there is an informal and open relationship between administrator and payer."

For an overview of biotechnology in Switzerland visit

Visit the Swiss Pavilion 3745 @ BIO 2008.

SOURCE Location Promotion Switzerland
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance
2. Cord Blood America in Top 20 in Los Angeles Area Biotech-Biomed Companies
3. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
4. As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report
5. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007
6. Quest Diagnostics Named to FORTUNE Magazines Americas Most Admired Companies List
7. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
8. Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
9. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
10. Top U.S. Cloning Companies Announce New System to Track Cloned Livestock
11. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
Post Your Comments:
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
(Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):